Etrasimod: Etrasimod tablet or granules by mouth, once daily up to 52 weeks of treatment.
The purpose of this study is to determine the safety, efficacy, and pharmacokinetics (PK) of etrasimod for the treatment of moderately to severely active ulcerative colitis in adolescents (≥ 12 years up to \< 18 years of age). Participants who will complete the total 52-week treatment period will have the opportunity to continue in a Long-Term Extension (LTE) Period of up to 4 years (5 years after study enrollment).
| Facility | City | Region | Status |
|---|---|---|---|
| Arkansas Children's (IP Address) | Little Rock | Arkansas | Not Yet Recruiting |
| Arkansas Children's | Little Rock | Arkansas | Not Yet Recruiting |
| Valley View Wellness Medical Center | Garden Grove | California | Recruiting |
| Loma Linda Children's Hospital | Loma Linda | California | Not Yet Recruiting |
| Loma Linda University Clinical Trial Center | Loma Linda | California | Not Yet Recruiting |
| Loma Linda University Eye Institute | Loma Linda | California | Not Yet Recruiting |
| Loma Linda University Medical Center | Loma Linda | California | Not Yet Recruiting |
| Loma Linda University Pediatric Clinics | Loma Linda | California | Not Yet Recruiting |
| Loma Linda University Children's Hospital Pediatric Specialty Clinics | San Bernardino | California | Not Yet Recruiting |
| University of California San Francisco, | San Francisco | California | Recruiting |
| University of California San Francisco | San Francisco | California | Recruiting |
| University of California,San Francisco Pediatric ClinicalResearch Center (PCRC) | San Francisco | California | Recruiting |
| Arnold Palmer Hospital - Center for Digestive Health and Nutrition | Orlando | Florida | Recruiting |
| University of Chicago Medical Center | Chicago | Illinois | Recruiting |
| Boston Children's Hospital | Boston | Massachusetts | Recruiting |
| William Beaumont Hospital/Corewell Health - East | Royal Oak | Michigan | Recruiting |
| William Beaumont Hospitals Reference Laboratory | Royal Oak | Michigan | Recruiting |
| University Hospitals Cleveland Medical Center Rainbow Babies & Children's Hospital | Cleveland | Ohio | Recruiting |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | Recruiting |
| ACT-Midwest G1 | Abilene | Texas | Recruiting |
| Tsujinaka Hospital - Kashiwanoha | Kashiwa | Chiba | Recruiting |
| Ishii Eye Clinic | Nagareyama-shi | Chiba | Recruiting |
| Gunma University Hospital | Maebashi | Gunma | Recruiting |
| Hyogo Medical University Hospital | Nishinomiya | Hyōgo | Recruiting |
| Kinki University - Nara Hospital | Ikoma | Nara | Recruiting |
| Saitama Prefectural Children's Medical Center | Saitama-shi | Saitama | Recruiting |
| Jichi Medical University Hospital | Shimotsuke | Tochigi | Recruiting |
| Juntendo University Hospital | Bunkyo-ku | Tokyo | Recruiting |
| Japanese Red Cross Kyoto Daini Hospital | Kyoto | Japan | Recruiting |
| Saga University Hospital | Saga | Japan | Recruiting |
| Toyama Prefectural Central Hospital | Toyama | Japan | Recruiting |
| WIP Warsaw IBD Point Profesor Kierkuś | Warsaw | Masovian Voivodeship | Recruiting |
| Instytut "Pomnik - Centrum Zdrowia Dziecka" (IPCZD) (The Children's Memorial Health Institute) | Warsaw | Masovian Voivodeship | Recruiting |
| Gyncentrum sp. z o.o. NZOZ Holsamed - oddział Libero | Katowice | Poland | Not Yet Recruiting |
| Uniwersytecki Szpital Dziecięcy w Krakowie | Krakow | Poland | Recruiting |
| Twoja Przychodnia - Szczecińskie Centrum Medyczne | Szczecin | Poland | Recruiting |
| Centrum Zdrowia MDM | Warsaw | Poland | Recruiting |
| WIP Warsaw IBD Point Profesor Kierkus | Warsaw | Poland | Recruiting |
| Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu | Wroclaw | Poland | Recruiting |
| Instytut Centrum Zdrowia Matki Polki | Lodz | Łódź Voivodeship | Active Not Recruiting |
+ 5 more sites — see the full list on the official registry below.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05287126 on ClinicalTrials.gov ↗ ← All trials in the USA